SHUKRAPHAR vs FSL: Stock Comparison

Head-to-head financial and trading comparison between Shukra Pharmaceuticals Limited (SHUKRAPHAR) and Firstsource Solutions Limited (FSL) in the Cross-Sector Peers sector.

SHUKRAPHAR

NSE: SHUKRAPHAR
Shukra Pharmaceuticals Limited
₹66.94
1Y Return: +61.61%
52W High: ₹72.58
52W Low: ₹41.42
Annual Volatility: 64.68%
Check SHUKRAPHAR Trade Fees →

FSL

NSE: FSL
Firstsource Solutions Limited
₹268.10
1Y Return: +15.04%
52W High: ₹339.45
52W Low: ₹209.27
Annual Volatility: 49.4%
Check FSL Trade Fees →

Key Metrics Comparison Table

MetricSHUKRAPHARFSLEdge / Winner
Current Market Price (CMP) ₹66.94 ₹268.10 —
1-Year Price Return +61.61% +15.04% SHUKRAPHAR (46.57% higher)
52-Week High ₹72.58 ₹339.45 —
52-Week Low ₹41.42 ₹209.27 —
30-Day Annualized Volatility 64.68% 49.4% FSL (Steadier)
30-Day Average Daily Volume 6,592,919 2,756,606 SHUKRAPHAR (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between SHUKRAPHAR and FSL, which stock gave better returns over the last year?

SHUKRAPHAR has outperformed FSL over the past 12 months with a gain of 61.61% compared to 15.04%.

Which stock is less volatile: SHUKRAPHAR or FSL?

FSL demonstrated lower price volatility (49.4% annualized) compared to SHUKRAPHAR (64.68%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of SHUKRAPHAR vs FSL?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are SHUKRAPHAR and FSL direct sector competitors?

Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.